TPIV - TapImmune Inc

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

TPIV - TapImmune Inc

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ
#2976()/7600

Tue 18'th Sep 2018

PERIOD 2018-06-19 - 2018-09-18
CHANGE -2.51%
PRICE $9.33
VOLUME
Buy
TREND
Sell

MV LONG
Buy

MV SHORT
Buy

PIVOT
Sell

MACD
Buy

Request Prediction
0.00%
Predict

TapImmune Inc Stock Analysis

Technical stock analysis for Tue 18'th Sep 2018

Hold candidate since 2018-09-18
Shorts 6.26% ( 2018-08-31 )
Cash n/a
Loans n/a
Beta -0.47
ROA -162.79

TapImmune Inc fell by -2.51% in the last day from $9.57 to $9.33 The price has fallen in 6 of the last 10 days and is down by -3.22% for this period. Volume has increased in the last day by 82 901 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 379 807 shares bought and sold for approximately $3.54 million.

Trend

TapImmune Inc lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $9.54 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -18.15% during the next 3 months and, with 90% probability hold a price between $4.51 and $7.81 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

TapImmune Inc holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $9.00 and $8.09. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Monday September 17, 2018, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 67 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

TapImmune Inc finds support from accumulated volume at $9.10.

Support: $9.10 Price: $9.33 Resistance: $10.83

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.19 between high and low, or 12.99%. For the last week, the stock has had a daily average volatility of 12.11%.

Our recommended stoploss: $8.86 (-4.99%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from pivot top found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation

TapImmune Inc holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Hold/Accumulate.

Hold/Accumulate

Click for Top 5 Hold/Accumulates
TPIV $9.33 $-0.24(-2.51%)
TPIV is down $0.24 today, but where's it headed in October?
Zacks Investment Research is releasing its prediction for TPIV based on the 1-3 month system that more than doubles the S&P 500.

Click here – the TPIV analysis is free »
Help us IMPROVE our CHARTS HERE.

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at


in partnership with
START FREE 5-DAY TRIAL